2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 128 filers reported holding 2SEVENTY BIO INC in Q4 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $7,260 | -39.4% | 1,357 | -51.7% | 0.00% | -100.0% |
| Q4 2023 | $11,986 | +8.9% | 2,807 | 0.0% | 0.00% | 0.0% |
| Q3 2023 | $11,003 | -61.3% | 2,807 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $28,407 | +28.8% | 2,807 | +29.8% | 0.00% | 0.0% |
| Q1 2023 | $22,063 | -2.1% | 2,163 | -10.1% | 0.00% | 0.0% |
| Q4 2022 | $22,535 | -35.6% | 2,405 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $34,993 | +10.2% | 2,405 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $31,746 | +26.2% | 2,405 | +63.2% | 0.00% | 0.0% |
| Q1 2022 | $25,146 | -84.3% | 1,474 | -76.4% | 0.00% | -50.0% |
| Q4 2021 | $160,188 | – | 6,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 684,996 | $9,885,521 | 8.20% |
| Madison Avenue Partners, LP | 1,199,832 | $11,242,426 | 1.99% |
| Newtyn Management, LLC | 882,134 | $8,265,596 | 1.71% |
| AlphaCentric Advisors LLC | 180,000 | $1,686,600 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $13,201 | 1.48% |
| Casdin Capital, LLC | 1,850,000 | $17,334,500 | 1.34% |
| CHI Advisors LLC | 333,252 | $3,122,571 | 0.83% |
| Birchview Capital, LP | 59,833 | $561 | 0.40% |
| TANG CAPITAL MANAGEMENT LLC | 250,000 | $2,342,500 | 0.34% |
| EcoR1 Capital, LLC | 1,143,494 | $10,714,539 | 0.33% |